World Cancer Meeting

Melbourne, Australia   November 16-17, 2017

Cancer Meeting 2017

Melbourne, Australia November 16-17, 2017

Theme: Enhancing Progression in Cancer Diagnosis & treatment

Track 1: Cancer is a group of disease involving abnormal cell development with the possibility to attack or spread to different parts of the body. Not all tumors are perilous; affable tumors don't spread to various parts of the body. Possible signs and reactions incorporate a knot, abnormal bleeding, prolonged cough, unexplained weight diminishment and an adjustment in solid discharges. While these reactions may show development, they may have distinctive causes. More than 100 sorts of diseases impact individuals. In spite of the way that tumor impacts singular patients and their families in different ways, concentrate its impact on enormous populace can give fundamental information that effects practices, game plans, and activities that direct impact the prosperity of an immense number of people .Various types of cancer include:

Carcinoma: Cancers derived from epithelial cells. This group incorporates countless most broadly perceived malignancies, particularly in older adults. All diseases observed in the bosom, prostate, lung, pancreas, and colon are carcinomas.

•Sarcoma: Sarcoma is a cancer which arises from transformed cells of mesenchymal origin.

•Lymphoma and leukemia: These two classes of growth emerge from cells that make blood. Leukemia is the most generally perceived kind of illness in adolescents speaking to around 30%. In any case, fundamentally more adults develop lymphoma and leukemia.

•Germ cell tumor: Cancers derived from pluripotent cells, frequently displaying in the gonad or the ovary (seminoma and dysgerminoma, separately).

•Blastoma: Cancers gotten from immature "antecedent" cells or embryonic tissue. Blastomas are more typical in adolescents than in adults.

Recommended Conferences:

World Cancer Congress, 1-4 October, 2017, Kuala Lumpur, Malaysia;59th American society of Hematology Annual Meeting & Exposition, December 9-12, Atlanta Georgia, United States; ESMO 2017 Congress, 8-12 September, 2017, Madrid, Spain;25th World Cancer Conference, 19-21, Rome, Italy; International Conference on Cancer Diagnostics, 27-28 November, Dubai, UAE;  2017 NCRI Cancer Conference, November 5-8, 2017 Liverpool; 19th World Cancer Conference, Nov 21-23, 2017 London; 26th World Cancer Convention, 27-28, November, 2017, Dubai, UAE; International Conference on Cancer Biology R&D and Market, September 18-19, 2017 Philadelphia, Pennsylvania, USA; 10th International Conference on Cancer Stem Cells and Oncology Research, June 26-28, 2017 London, UK; International Conference on Hematology and Oncology, June 29-July 01, 2017 Bangkok, Thailand; 19th Euro Congress on Cancer Science and Therapy, July 17-19, 2017 Lisbon, Portugal; 3rd Annual Conference on Gynecologic Oncology & Preventive Oncology, July 20-21, 2017 Chicago, Illinois, USA; 4th International Conference and Exhibition on Medical Physics and Biophysics, July 27-28, 2017 Rome, Italy; 20th Euro-Global Summit on Cancer Therapy & Radiation Oncology, August 28-29, 2017 Brussels, Belgium; Oncologist & Diagnostics Conference, August 28-30, 2017 Brussels, Belgium; 2nd International Congress on Contemporary Issues in Women Cancers & Gynecologic Oncology, Aug 29-30, 2017 London, UK; 9th International Conference on Leukemia and Hematologic Oncology, October 05-06,2017,  London, UK; International Conference on Gastrointestinal Cancer and Therapeutics October 16-18, 2017 Baltimore, USA; 25th World Congress on Cancer Science and Therapy, October 18-20, 2017 Baltimore, Maryland, USA; World Congress on Radiology and Oncology, October 19-20, 2017 New York, USA; 25th World Cancer Conference, Oct 19-21, 2017 Rome, Italy; 9th International Conference on Biomarkers, October 26-28, 2017 Osaka, Japan; International Conference on Cancer Genetics and Epigenetics, October 26-28 2017, Osaka, Japan; 2nd International Congress on Epigenetics & Chromatin, November 06-08, 2017,Frankfurt, Germany; 14th Asia Pacific Oncologists Annual Meeting, November 20-22, 2017 Melbourne, Australia; 9th World Biomarkers Congress, December 07-08, 2017, Madrid, Spain; Global Summit on Oncology & Cancer, March 12-14, 2018, Singapore; 22nd Global Annual Oncologists Meeting, May 24-25, 2018 Osaka, Japan; Asia Pacific Cancer Conference, June 22-24, 2017, Seoul, Korea; Expediting Global Innovation in Precision Cancer Medicine, June 26-27, Paris; 4th international Michelangelo Conference Promises and challenges of developing new drugs in oncology, July 6-7, 2017;

Related associations:

European Association for Cancer Research, American Association for Cancer Research, American society of Clinical Oncology, American Cancer Society, Singapore Cancer Society, World Health Organization, American Childhood Cancer Organization, National Cancer Centre Singapore, Australia: Leukaemia Foundation, Australian & New Zealand Children’s Hematology/Oncology Group, Australian Prostate Cancer Research Centre.

Track 2: Cancer Biology  Cancer cells are normally tested by their capacity to segment fiercely. Hazardous tumors are hurtful, which suggests they can spread into, or assault, nearby tissues. Additionally, as these tumors build up, some malignancy cells can separate and go to distant spots in the body through the blood or the lymph structure and shape new tumors far from the primary tumor. Malignancy cells rise up out of the body's own particular tissues. Development Cell Biology fuses the nuclear, biochemical, and cell-based approaches to manage better comprehend tumor pathogenesis. Researchers today have a developing comprehension of the science of a vast array of cancers driven by different changes and crosswise over many body sites. New information and research approaches have made open doors for specialists to think about in detail numerous parts of malignancy science, including how the ordinary natural projects of cell expansion and death are adjusted during cancer and how the immune system reacts to tumors.

Recommended Conferences:

World Cancer Congress, 1-4 October, 2017, Kuala Lumpur, Malaysia;59th American society of Hematology Annual Meeting & Exposition, December 9-12, Atlanta Georgia, United States; ESMO 2017 Congress, 8-12 September, 2017, Madrid, Spain;25th World Cancer Conference, 19-21, Rome, Italy; International Conference on Cancer Diagnostics, 27-28 November, Dubai, UAE;  2017 NCRI Cancer Conference, November 5-8, 2017 Liverpool; 19th World Cancer Conference, Nov 21-23, 2017 London; 26th World Cancer Convention, 27-28, November, 2017, Dubai, UAE; International Conference on Cancer Biology R&D and Market, September 18-19, 2017 Philadelphia, Pennsylvania, USA; 10th International Conference on Cancer Stem Cells and Oncology Research, June 26-28, 2017 London, UK; International Conference on Hematology and Oncology, June 29-July 01, 2017 Bangkok, Thailand; 19th Euro Congress on Cancer Science and Therapy, July 17-19, 2017 Lisbon, Portugal; 3rd Annual Conference on Gynecologic Oncology & Preventive Oncology, July 20-21, 2017 Chicago, Illinois, USA; 4th International Conference and Exhibition on Medical Physics and Biophysics, July 27-28, 2017 Rome, Italy; 20th Euro-Global Summit on Cancer Therapy & Radiation Oncology, August 28-29, 2017 Brussels, Belgium; Oncologist & Diagnostics Conference, August 28-30, 2017 Brussels, Belgium; 2nd International Congress on Contemporary Issues in Women Cancers & Gynecologic Oncology, Aug 29-30, 2017 London, UK; 9th International Conference on Leukemia and Hematologic Oncology, October 05-06,2017,  London, UK; International Conference on Gastrointestinal Cancer and Therapeutics October 16-18, 2017 Baltimore, USA; 25th World Congress on Cancer Science and Therapy, October 18-20, 2017 Baltimore, Maryland, USA; World Congress on Radiology and Oncology, October 19-20, 2017 New York, USA; 25th World Cancer Conference, Oct 19-21, 2017 Rome, Italy; 9th International Conference on Biomarkers, October 26-28, 2017 Osaka, Japan; International Conference on Cancer Genetics and Epigenetics, October 26-28 2017, Osaka, Japan; 2nd International Congress on Epigenetics & Chromatin, November 06-08, 2017,Frankfurt, Germany; 14th Asia Pacific Oncologists Annual Meeting, November 20-22, 2017 Melbourne, Australia; 9th World Biomarkers Congress, December 07-08, 2017, Madrid, Spain; Global Summit on Oncology & Cancer, March 12-14, 2018, Singapore; 22nd Global Annual Oncologists Meeting, May 24-25, 2018 Osaka, Japan; Asia Pacific Cancer Conference, June 22-24, 2017, Seoul, Korea; Expediting Global Innovation in Precision Cancer Medicine, June 26-27, Paris; 4th international Michelangelo Conference Promises and challenges of developing new drugs in oncology, July 6-7, 2017;

Related associations:

European Association for Cancer Research, American Association for Cancer Research, American society of Clinical Oncology, American Cancer Society, Singapore Cancer Society, World Health Organization, American Childhood Cancer Organization, National Cancer Centre Singapore, Australia: Leukaemia Foundation, Australian & New Zealand Children’s Hematology/Oncology Group, Australian Prostate Cancer Research Centre.

Track 3: Cancer Genetics Cancer is a hereditary infection that is, cancer is brought about by specific changes to qualities that control the way our cells work, particularly how they develop and separate. Tumor bringing on hereditary changes can correspondingly be secured amidst one's lifetime, as the consequence of slip-ups that happen as cells cleft amidst a man's lifetime or prologue to substances, for example, certain chemicals in tobacco smoke, and radiation, for instance, brilliant bars from the sun, that mischief DNA. Tumors that are not made by obtained innate changes can once in a while appear to "continue running in families."

Recommended Conferences:

World Cancer Congress, 1-4 October, 2017, Kuala Lumpur, Malaysia;59th American society of Hematology Annual Meeting & Exposition, December 9-12, Atlanta Georgia, United States; ESMO 2017 Congress, 8-12 September, 2017, Madrid, Spain;25th World Cancer Conference, 19-21, Rome, Italy; International Conference on Cancer Diagnostics, 27-28 November, Dubai, UAE;  2017 NCRI Cancer Conference, November 5-8, 2017 Liverpool; 19th World Cancer Conference, Nov 21-23, 2017 London; 26th World Cancer Convention, 27-28, November, 2017, Dubai, UAE; International Conference on Cancer Biology R&D and Market, September 18-19, 2017 Philadelphia, Pennsylvania, USA; 10th International Conference on Cancer Stem Cells and Oncology Research, June 26-28, 2017 London, UK; International Conference on Hematology and Oncology, June 29-July 01, 2017 Bangkok, Thailand; 19th Euro Congress on Cancer Science and Therapy, July 17-19, 2017 Lisbon, Portugal; 3rd Annual Conference on Gynecologic Oncology & Preventive Oncology, July 20-21, 2017 Chicago, Illinois, USA; 4th International Conference and Exhibition on Medical Physics and Biophysics, July 27-28, 2017 Rome, Italy; 20th Euro-Global Summit on Cancer Therapy & Radiation Oncology, August 28-29, 2017 Brussels, Belgium; Oncologist & Diagnostics Conference, August 28-30, 2017 Brussels, Belgium; 2nd International Congress on Contemporary Issues in Women Cancers & Gynecologic Oncology, Aug 29-30, 2017 London, UK; 9th International Conference on Leukemia and Hematologic Oncology, October 05-06,2017,  London, UK; International Conference on Gastrointestinal Cancer and Therapeutics October 16-18, 2017 Baltimore, USA; 25th World Congress on Cancer Science and Therapy, October 18-20, 2017 Baltimore, Maryland, USA; World Congress on Radiology and Oncology, October 19-20, 2017 New York, USA; 25th World Cancer Conference, Oct 19-21, 2017 Rome, Italy; 9th International Conference on Biomarkers, October 26-28, 2017 Osaka, Japan; International Conference on Cancer Genetics and Epigenetics, October 26-28 2017, Osaka, Japan; 2nd International Congress on Epigenetics & Chromatin, November 06-08, 2017,Frankfurt, Germany; 14th Asia Pacific Oncologists Annual Meeting, November 20-22, 2017 Melbourne, Australia; 9th World Biomarkers Congress, December 07-08, 2017, Madrid, Spain; Global Summit on Oncology & Cancer, March 12-14, 2018, Singapore; 22nd Global Annual Oncologists Meeting, May 24-25, 2018 Osaka, Japan; Asia Pacific Cancer Conference, June 22-24, 2017, Seoul, Korea; Expediting Global Innovation in Precision Cancer Medicine, June 26-27, Paris; 4th international Michelangelo Conference Promises and challenges of developing new drugs in oncology, July 6-7, 2017;

Related associations:

European Association for Cancer Research, American Association for Cancer Research, American society of Clinical Oncology, American Cancer Society, Singapore Cancer Society, World Health Organization, American Childhood Cancer Organization, National Cancer Centre Singapore, Australia: Leukaemia Foundation, Australian & New Zealand Children’s Hematology/Oncology Group, Australian Prostate Cancer Research Centre.

Track 4: Precision Medicine and Cancer Therapy Precision arrangement generally called Personalized Medicine is an expression that is frequently used to depict how innate information about a man's ailment is being used to break down or treat their infection. Currently, if you require treatment for cancer, you may get a mix of medications, including surgery, chemotherapy, radiation treatment, and immunotherapy. The more significant cognizance of how development shapes and creates has presented another period of accuracy malignancy mind, where exclusively fitted prescriptions target varieties from the standard that may be found in each tumor's DNA profile. This stimulating improvement mean a move, from regular prescriptions planned for the ordinary patient in light of their prosperity with a specialist trial of people with similar developments, toward more correct medicines.

Recommended Conferences:

World Cancer Congress, 1-4 October, 2017, Kuala Lumpur, Malaysia;59th American society of Hematology Annual Meeting & Exposition, December 9-12, Atlanta Georgia, United States; ESMO 2017 Congress, 8-12 September, 2017, Madrid, Spain;25th World Cancer Conference, 19-21, Rome, Italy; International Conference on Cancer Diagnostics, 27-28 November, Dubai, UAE;  2017 NCRI Cancer Conference, November 5-8, 2017 Liverpool; 19th World Cancer Conference, Nov 21-23, 2017 London; 26th World Cancer Convention, 27-28, November, 2017, Dubai, UAE; International Conference on Cancer Biology R&D and Market, September 18-19, 2017 Philadelphia, Pennsylvania, USA; 10th International Conference on Cancer Stem Cells and Oncology Research, June 26-28, 2017 London, UK; International Conference on Hematology and Oncology, June 29-July 01, 2017 Bangkok, Thailand; 19th Euro Congress on Cancer Science and Therapy, July 17-19, 2017 Lisbon, Portugal; 3rd Annual Conference on Gynecologic Oncology & Preventive Oncology, July 20-21, 2017 Chicago, Illinois, USA; 4th International Conference and Exhibition on Medical Physics and Biophysics, July 27-28, 2017 Rome, Italy; 20th Euro-Global Summit on Cancer Therapy & Radiation Oncology, August 28-29, 2017 Brussels, Belgium; Oncologist & Diagnostics Conference, August 28-30, 2017 Brussels, Belgium; 2nd International Congress on Contemporary Issues in Women Cancers & Gynecologic Oncology, Aug 29-30, 2017 London, UK; 9th International Conference on Leukemia and Hematologic Oncology, October 05-06,2017,  London, UK; International Conference on Gastrointestinal Cancer and Therapeutics October 16-18, 2017 Baltimore, USA; 25th World Congress on Cancer Science and Therapy, October 18-20, 2017 Baltimore, Maryland, USA; World Congress on Radiology and Oncology, October 19-20, 2017 New York, USA; 25th World Cancer Conference, Oct 19-21, 2017 Rome, Italy; 9th International Conference on Biomarkers, October 26-28, 2017 Osaka, Japan; International Conference on Cancer Genetics and Epigenetics, October 26-28 2017, Osaka, Japan; 2nd International Congress on Epigenetics & Chromatin, November 06-08, 2017,Frankfurt, Germany; 14th Asia Pacific Oncologists Annual Meeting, November 20-22, 2017 Melbourne, Australia; 9th World Biomarkers Congress, December 07-08, 2017, Madrid, Spain; Global Summit on Oncology & Cancer, March 12-14, 2018, Singapore; 22nd Global Annual Oncologists Meeting, May 24-25, 2018 Osaka, Japan; Asia Pacific Cancer Conference, June 22-24, 2017, Seoul, Korea; Expediting Global Innovation in Precision Cancer Medicine, June 26-27, Paris; 4th international Michelangelo Conference Promises and challenges of developing new drugs in oncology, July 6-7, 2017;

Related associations:

European Association for Cancer Research, American Association for Cancer Research, American society of Clinical Oncology, American Cancer Society, Singapore Cancer Society, World Health Organization, American Childhood Cancer Organization, National Cancer Centre Singapore, Australia: Leukaemia Foundation, Australian & New Zealand Children’s Hematology/Oncology Group, Australian Prostate Cancer Research Centre.

Track 5: Cancer Diagnosis and Cancer Diagnostics Analytic testing incorporates into test and the framework to get the consistence about the sickness. There are various sorts of tests to conclude the development. Biopsy test is most typical test to distinguish the growth. There are different types of biopsies which incorporate Needle biopsy, Aspiration biopsy, Prostate biopsy, Liver biopsy, Skin biopsy. Endoscopy technique specially embeds an endoscope through little cut, or an opening in the body .In light of Technology (ELISA, ELFA, PCR, NGS, Immunohistochemistry, Microarray, Imaging (MRI, CT, PET, Ultrasound, Mammography), Biopsy, the tumor diagnostics business sector is characterized into stage develop and instrument-based with respect to  the application, the malignancy diagnostics business area is separated into lung disease, chest development, colorectal malignancy, melanoma, and others. On the premise of area, the business segment is isolated into North America, Europe, Asia, and Rest of the World .The Cancer Diagnostics Market incorporates distinctive parts of treatment Rest of the World contains Latin America, Pacific countries, and Middle East and Africa. North America is required to speak to the greatest offer in the development diagnostics advertise, trailed by Europe and Asia.

Recommended Conferences:

World Cancer Congress, 1-4 October, 2017, Kuala Lumpur, Malaysia;59th American society of Hematology Annual Meeting & Exposition, December 9-12, Atlanta Georgia, United States; ESMO 2017 Congress, 8-12 September, 2017, Madrid, Spain;25th World Cancer Conference, 19-21, Rome, Italy; International Conference on Cancer Diagnostics, 27-28 November, Dubai, UAE;  2017 NCRI Cancer Conference, November 5-8, 2017 Liverpool; 19th World Cancer Conference, Nov 21-23, 2017 London; 26th World Cancer Convention, 27-28, November, 2017, Dubai, UAE; International Conference on Cancer Biology R&D and Market, September 18-19, 2017 Philadelphia, Pennsylvania, USA; 10th International Conference on Cancer Stem Cells and Oncology Research, June 26-28, 2017 London, UK; International Conference on Hematology and Oncology, June 29-July 01, 2017 Bangkok, Thailand; 19th Euro Congress on Cancer Science and Therapy, July 17-19, 2017 Lisbon, Portugal; 3rd Annual Conference on Gynecologic Oncology & Preventive Oncology, July 20-21, 2017 Chicago, Illinois, USA; 4th International Conference and Exhibition on Medical Physics and Biophysics, July 27-28, 2017 Rome, Italy; 20th Euro-Global Summit on Cancer Therapy & Radiation Oncology, August 28-29, 2017 Brussels, Belgium; Oncologist & Diagnostics Conference, August 28-30, 2017 Brussels, Belgium; 2nd International Congress on Contemporary Issues in Women Cancers & Gynecologic Oncology, Aug 29-30, 2017 London, UK; 9th International Conference on Leukemia and Hematologic Oncology, October 05-06,2017,  London, UK; International Conference on Gastrointestinal Cancer and Therapeutics October 16-18, 2017 Baltimore, USA; 25th World Congress on Cancer Science and Therapy, October 18-20, 2017 Baltimore, Maryland, USA; World Congress on Radiology and Oncology, October 19-20, 2017 New York, USA; 25th World Cancer Conference, Oct 19-21, 2017 Rome, Italy; 9th International Conference on Biomarkers, October 26-28, 2017 Osaka, Japan; International Conference on Cancer Genetics and Epigenetics, October 26-28 2017, Osaka, Japan; 2nd International Congress on Epigenetics & Chromatin, November 06-08, 2017,Frankfurt, Germany; 14th Asia Pacific Oncologists Annual Meeting, November 20-22, 2017 Melbourne, Australia; 9th World Biomarkers Congress, December 07-08, 2017, Madrid, Spain; Global Summit on Oncology & Cancer, March 12-14, 2018, Singapore; 22nd Global Annual Oncologists Meeting, May 24-25, 2018 Osaka, Japan; Asia Pacific Cancer Conference, June 22-24, 2017, Seoul, Korea; Expediting Global Innovation in Precision Cancer Medicine, June 26-27, Paris; 4th international Michelangelo Conference Promises and challenges of developing new drugs in oncology, July 6-7, 2017;

Related associations:

European Association for Cancer Research, American Association for Cancer Research, American society of Clinical Oncology, American Cancer Society, Singapore Cancer Society, World Health Organization, American Childhood Cancer Organization, National Cancer Centre Singapore, Australia: Leukaemia Foundation, Australian & New Zealand Children’s Hematology/Oncology Group, Australian Prostate Cancer Research Centre.

Track 6: Stem cell Therapy Stem Cells and Tumors disease cells also have the trademark which is in likewise associated with normal stems cells. Undifferentiated organism Therapy is use to keep the infection .The most surely understood undeveloped cells treatment is bone marrow transplant. Stems cells transplant is used for treatment of malady like leukemia, different myeloma of lymphoma. Line Blood Stem and Cancer line blood contains haematopoietic (blood) undifferentiated cell ,these cells make distinctive sorts of cells like red platelets white platelets Haematopoietic immature microorganisms, purified from bone marrow or blood, have for a long while been used as a piece of foundational microorganism medicine for leukemia, blood and bone marrow issue when chemotherapy is used.

Recommended Conferences:

World Cancer Congress, 1-4 October, 2017, Kuala Lumpur, Malaysia;59th American society of Hematology Annual Meeting & Exposition, December 9-12, Atlanta Georgia, United States; ESMO 2017 Congress, 8-12 September, 2017, Madrid, Spain;25th World Cancer Conference, 19-21, Rome, Italy; International Conference on Cancer Diagnostics, 27-28 November, Dubai, UAE;  2017 NCRI Cancer Conference, November 5-8, 2017 Liverpool; 19th World Cancer Conference, Nov 21-23, 2017 London; 26th World Cancer Convention, 27-28, November, 2017, Dubai, UAE; International Conference on Cancer Biology R&D and Market, September 18-19, 2017 Philadelphia, Pennsylvania, USA; 10th International Conference on Cancer Stem Cells and Oncology Research, June 26-28, 2017 London, UK; International Conference on Hematology and Oncology, June 29-July 01, 2017 Bangkok, Thailand; 19th Euro Congress on Cancer Science and Therapy, July 17-19, 2017 Lisbon, Portugal; 3rd Annual Conference on Gynecologic Oncology & Preventive Oncology, July 20-21, 2017 Chicago, Illinois, USA; 4th International Conference and Exhibition on Medical Physics and Biophysics, July 27-28, 2017 Rome, Italy; 20th Euro-Global Summit on Cancer Therapy & Radiation Oncology, August 28-29, 2017 Brussels, Belgium; Oncologist & Diagnostics Conference, August 28-30, 2017 Brussels, Belgium; 2nd International Congress on Contemporary Issues in Women Cancers & Gynecologic Oncology, Aug 29-30, 2017 London, UK; 9th International Conference on Leukemia and Hematologic Oncology, October 05-06,2017,  London, UK; International Conference on Gastrointestinal Cancer and Therapeutics October 16-18, 2017 Baltimore, USA; 25th World Congress on Cancer Science and Therapy, October 18-20, 2017 Baltimore, Maryland, USA; World Congress on Radiology and Oncology, October 19-20, 2017 New York, USA; 25th World Cancer Conference, Oct 19-21, 2017 Rome, Italy; 9th International Conference on Biomarkers, October 26-28, 2017 Osaka, Japan; International Conference on Cancer Genetics and Epigenetics, October 26-28 2017, Osaka, Japan; 2nd International Congress on Epigenetics & Chromatin, November 06-08, 2017,Frankfurt, Germany; 14th Asia Pacific Oncologists Annual Meeting, November 20-22, 2017 Melbourne, Australia; 9th World Biomarkers Congress, December 07-08, 2017, Madrid, Spain; Global Summit on Oncology & Cancer, March 12-14, 2018, Singapore; 22nd Global Annual Oncologists Meeting, May 24-25, 2018 Osaka, Japan; Asia Pacific Cancer Conference, June 22-24, 2017, Seoul, Korea; Expediting Global Innovation in Precision Cancer Medicine, June 26-27, Paris; 4th international Michelangelo Conference Promises and challenges of developing new drugs in oncology, July 6-7, 2017;

Related associations:

European Association for Cancer Research, American Association for Cancer Research, American society of Clinical Oncology, American Cancer Society, Singapore Cancer Society, World Health Organization, American Childhood Cancer Organization, National Cancer Centre Singapore, Australia: Leukaemia Foundation, Australian & New Zealand Children’s Hematology/Oncology Group, Australian Prostate Cancer Research Centre.

Track 7: Cancer Case Reports A case report implies the point by point report of reactions, signs, assurance, treatment, and follow-up of an individual patient of a particular ailment. Tumor Case reports have been expecting a basic part in therapeutic training, giving a structure to case-based learning and execution all through the world.

Recommended Conferences:

World Cancer Congress, 1-4 October, 2017, Kuala Lumpur, Malaysia;59th American society of Hematology Annual Meeting & Exposition, December 9-12, Atlanta Georgia, United States; ESMO 2017 Congress, 8-12 September, 2017, Madrid, Spain;25th World Cancer Conference, 19-21, Rome, Italy; International Conference on Cancer Diagnostics, 27-28 November, Dubai, UAE;  2017 NCRI Cancer Conference, November 5-8, 2017 Liverpool; 19th World Cancer Conference, Nov 21-23, 2017 London; 26th World Cancer Convention, 27-28, November, 2017, Dubai, UAE; International Conference on Cancer Biology R&D and Market, September 18-19, 2017 Philadelphia, Pennsylvania, USA; 10th International Conference on Cancer Stem Cells and Oncology Research, June 26-28, 2017 London, UK; International Conference on Hematology and Oncology, June 29-July 01, 2017 Bangkok, Thailand; 19th Euro Congress on Cancer Science and Therapy, July 17-19, 2017 Lisbon, Portugal; 3rd Annual Conference on Gynecologic Oncology & Preventive Oncology, July 20-21, 2017 Chicago, Illinois, USA; 4th International Conference and Exhibition on Medical Physics and Biophysics, July 27-28, 2017 Rome, Italy; 20th Euro-Global Summit on Cancer Therapy & Radiation Oncology, August 28-29, 2017 Brussels, Belgium; Oncologist & Diagnostics Conference, August 28-30, 2017 Brussels, Belgium; 2nd International Congress on Contemporary Issues in Women Cancers & Gynecologic Oncology, Aug 29-30, 2017 London, UK; 9th International Conference on Leukemia and Hematologic Oncology, October 05-06,2017,  London, UK; International Conference on Gastrointestinal Cancer and Therapeutics October 16-18, 2017 Baltimore, USA; 25th World Congress on Cancer Science and Therapy, October 18-20, 2017 Baltimore, Maryland, USA; World Congress on Radiology and Oncology, October 19-20, 2017 New York, USA; 25th World Cancer Conference, Oct 19-21, 2017 Rome, Italy; 9th International Conference on Biomarkers, October 26-28, 2017 Osaka, Japan; International Conference on Cancer Genetics and Epigenetics, October 26-28 2017, Osaka, Japan; 2nd International Congress on Epigenetics & Chromatin, November 06-08, 2017,Frankfurt, Germany; 14th Asia Pacific Oncologists Annual Meeting, November 20-22, 2017 Melbourne, Australia; 9th World Biomarkers Congress, December 07-08, 2017, Madrid, Spain; Global Summit on Oncology & Cancer, March 12-14, 2018, Singapore; 22nd Global Annual Oncologists Meeting, May 24-25, 2018 Osaka, Japan; Asia Pacific Cancer Conference, June 22-24, 2017, Seoul, Korea; Expediting Global Innovation in Precision Cancer Medicine, June 26-27, Paris; 4th international Michelangelo Conference Promises and challenges of developing new drugs in oncology, July 6-7, 2017;

Related associations:

European Association for Cancer Research, American Association for Cancer Research, American society of Clinical Oncology, American Cancer Society, Singapore Cancer Society, World Health Organization, American Childhood Cancer Organization, National Cancer Centre Singapore, Australia: Leukaemia Foundation, Australian & New Zealand Children’s Hematology/Oncology Group, Australian Prostate Cancer Research Centre.

Track 8: Novel Approaches to Cancer Therapeutics The Normal treatment modalities are associated with genuine responses and high toxic quality which along these lines incite to low individual satisfaction. This review encompasses novel strategies for more successful chemotherapeutic movement hoping to deliver better estimate. At present, disease treatment is a significantly unique field and vital advances are being made in the change of novel tumor treatment techniques. Rather than conventional malignancy therapeutics, novel approaches, for instance, ligand or receptor based focusing on, intracellular medicine concentrating on, quality movement, development undifferentiated cell treatment, alluring prescription concentrating on and ultrasound-mediated sedate transport, have included new modalities for tumor treatment.

Recommended Conferences:

World Cancer Congress, 1-4 October, 2017, Kuala Lumpur, Malaysia;59th American society of Hematology Annual Meeting & Exposition, December 9-12, Atlanta Georgia, United States; ESMO 2017 Congress, 8-12 September, 2017, Madrid, Spain;25th World Cancer Conference, 19-21, Rome, Italy; International Conference on Cancer Diagnostics, 27-28 November, Dubai, UAE;  2017 NCRI Cancer Conference, November 5-8, 2017 Liverpool; 19th World Cancer Conference, Nov 21-23, 2017 London; 26th World Cancer Convention, 27-28, November, 2017, Dubai, UAE; International Conference on Cancer Biology R&D and Market, September 18-19, 2017 Philadelphia, Pennsylvania, USA; 10th International Conference on Cancer Stem Cells and Oncology Research, June 26-28, 2017 London, UK; International Conference on Hematology and Oncology, June 29-July 01, 2017 Bangkok, Thailand; 19th Euro Congress on Cancer Science and Therapy, July 17-19, 2017 Lisbon, Portugal; 3rd Annual Conference on Gynecologic Oncology & Preventive Oncology, July 20-21, 2017 Chicago, Illinois, USA; 4th International Conference and Exhibition on Medical Physics and Biophysics, July 27-28, 2017 Rome, Italy; 20th Euro-Global Summit on Cancer Therapy & Radiation Oncology, August 28-29, 2017 Brussels, Belgium; Oncologist & Diagnostics Conference, August 28-30, 2017 Brussels, Belgium; 2nd International Congress on Contemporary Issues in Women Cancers & Gynecologic Oncology, Aug 29-30, 2017 London, UK; 9th International Conference on Leukemia and Hematologic Oncology, October 05-06,2017,  London, UK; International Conference on Gastrointestinal Cancer and Therapeutics October 16-18, 2017 Baltimore, USA; 25th World Congress on Cancer Science and Therapy, October 18-20, 2017 Baltimore, Maryland, USA; World Congress on Radiology and Oncology, October 19-20, 2017 New York, USA; 25th World Cancer Conference, Oct 19-21, 2017 Rome, Italy; 9th International Conference on Biomarkers, October 26-28, 2017 Osaka, Japan; International Conference on Cancer Genetics and Epigenetics, October 26-28 2017, Osaka, Japan; 2nd International Congress on Epigenetics & Chromatin, November 06-08, 2017,Frankfurt, Germany; 14th Asia Pacific Oncologists Annual Meeting, November 20-22, 2017 Melbourne, Australia; 9th World Biomarkers Congress, December 07-08, 2017, Madrid, Spain; Global Summit on Oncology & Cancer, March 12-14, 2018, Singapore; 22nd Global Annual Oncologists Meeting, May 24-25, 2018 Osaka, Japan; Asia Pacific Cancer Conference, June 22-24, 2017, Seoul, Korea; Expediting Global Innovation in Precision Cancer Medicine, June 26-27, Paris; 4th international Michelangelo Conference Promises and challenges of developing new drugs in oncology, July 6-7, 2017;

Related associations:

European Association for Cancer Research, American Association for Cancer Research, American society of Clinical Oncology, American Cancer Society, Singapore Cancer Society, World Health Organization, American Childhood Cancer Organization, National Cancer Centre Singapore, Australia: Leukaemia Foundation, Australian & New Zealand Children’s Hematology/Oncology Group, Australian Prostate Cancer Research Centre.

Track 9: Cancer Screening Growth can be managed by surgery, chemotherapy, radiation treatment, hormonal treatment, Mammography and concentrated on treatment. The choice of treatment depends on the zone and grade of the tumor and the period of the disease, and furthermore the general state of the patient. Different test tumor solutions are furthermore a work in advance. Occasionally this can be capable by surgery, yet the slant of developments to assault close-by tissue or to spread to out of reach goals by moment metastasis much of the time limits its reasonability; and chemotherapy and radiotherapy can adversely influence conventional cells. In this manner, cure with not irrelevant negative effects may be recognized as a conventional target from time to time; what's all the more recuperating point, reasonable destinations of treatment can moreover fuse covering the threat to a subclinical state and keeping up that state for an impressive time span of good individual fulfillment, and palliative care without restorative desire (for front line orchestrate metastatic infections).

Recommended Conferences:

World Cancer Congress, 1-4 October, 2017, Kuala Lumpur, Malaysia;59th American society of Hematology Annual Meeting & Exposition, December 9-12, Atlanta Georgia, United States; ESMO 2017 Congress, 8-12 September, 2017, Madrid, Spain;25th World Cancer Conference, 19-21, Rome, Italy; International Conference on Cancer Diagnostics, 27-28 November, Dubai, UAE;  2017 NCRI Cancer Conference, November 5-8, 2017 Liverpool; 19th World Cancer Conference, Nov 21-23, 2017 London; 26th World Cancer Convention, 27-28, November, 2017, Dubai, UAE; International Conference on Cancer Biology R&D and Market, September 18-19, 2017 Philadelphia, Pennsylvania, USA; 10th International Conference on Cancer Stem Cells and Oncology Research, June 26-28, 2017 London, UK; International Conference on Hematology and Oncology, June 29-July 01, 2017 Bangkok, Thailand; 19th Euro Congress on Cancer Science and Therapy, July 17-19, 2017 Lisbon, Portugal; 3rd Annual Conference on Gynecologic Oncology & Preventive Oncology, July 20-21, 2017 Chicago, Illinois, USA; 4th International Conference and Exhibition on Medical Physics and Biophysics, July 27-28, 2017 Rome, Italy; 20th Euro-Global Summit on Cancer Therapy & Radiation Oncology, August 28-29, 2017 Brussels, Belgium; Oncologist & Diagnostics Conference, August 28-30, 2017 Brussels, Belgium; 2nd International Congress on Contemporary Issues in Women Cancers & Gynecologic Oncology, Aug 29-30, 2017 London, UK; 9th International Conference on Leukemia and Hematologic Oncology, October 05-06,2017,  London, UK; International Conference on Gastrointestinal Cancer and Therapeutics October 16-18, 2017 Baltimore, USA; 25th World Congress on Cancer Science and Therapy, October 18-20, 2017 Baltimore, Maryland, USA; World Congress on Radiology and Oncology, October 19-20, 2017 New York, USA; 25th World Cancer Conference, Oct 19-21, 2017 Rome, Italy; 9th International Conference on Biomarkers, October 26-28, 2017 Osaka, Japan; International Conference on Cancer Genetics and Epigenetics, October 26-28 2017, Osaka, Japan; 2nd International Congress on Epigenetics & Chromatin, November 06-08, 2017,Frankfurt, Germany; 14th Asia Pacific Oncologists Annual Meeting, November 20-22, 2017 Melbourne, Australia; 9th World Biomarkers Congress, December 07-08, 2017, Madrid, Spain; Global Summit on Oncology & Cancer, March 12-14, 2018, Singapore; 22nd Global Annual Oncologists Meeting, May 24-25, 2018 Osaka, Japan; Asia Pacific Cancer Conference, June 22-24, 2017, Seoul, Korea; Expediting Global Innovation in Precision Cancer Medicine, June 26-27, Paris; 4th international Michelangelo Conference Promises and challenges of developing new drugs in oncology, July 6-7, 2017;

Related associations:

European Association for Cancer Research, American Association for Cancer Research, American society of Clinical Oncology, American Cancer Society, Singapore Cancer Society, World Health Organization, American Childhood Cancer Organization, National Cancer Centre Singapore, Australia: Leukaemia Foundation, Australian & New Zealand Children’s Hematology/Oncology Group, Australian Prostate Cancer Research Centre.

Track 10: Resistance and Tumor Evolution Acquired medication resistance is a noteworthy constraint for effective treatment of growth. Resistance rises because of medication prohibition, sedate digestion and modification of the medication focus by transformation or overexpression. Contingent upon treatment, the kind of disease and its stage, one or a few hereditary or epigenetic modifications are important to present imperviousness to treatment. Malignancy development is the single greatest test we confront in making better medications for patients .We require a deliberate push to move our approach and concentrate basically all that we do on suspecting, outpacing and beating disease advancement.

Recommended Conferences:

World Cancer Congress, 1-4 October, 2017, Kuala Lumpur, Malaysia;59th American society of Hematology Annual Meeting & Exposition, December 9-12, Atlanta Georgia, United States; ESMO 2017 Congress, 8-12 September, 2017, Madrid, Spain;25th World Cancer Conference, 19-21, Rome, Italy; International Conference on Cancer Diagnostics, 27-28 November, Dubai, UAE;  2017 NCRI Cancer Conference, November 5-8, 2017 Liverpool; 19th World Cancer Conference, Nov 21-23, 2017 London; 26th World Cancer Convention, 27-28, November, 2017, Dubai, UAE; International Conference on Cancer Biology R&D and Market, September 18-19, 2017 Philadelphia, Pennsylvania, USA; 10th International Conference on Cancer Stem Cells and Oncology Research, June 26-28, 2017 London, UK; International Conference on Hematology and Oncology, June 29-July 01, 2017 Bangkok, Thailand; 19th Euro Congress on Cancer Science and Therapy, July 17-19, 2017 Lisbon, Portugal; 3rd Annual Conference on Gynecologic Oncology & Preventive Oncology, July 20-21, 2017 Chicago, Illinois, USA; 4th International Conference and Exhibition on Medical Physics and Biophysics, July 27-28, 2017 Rome, Italy; 20th Euro-Global Summit on Cancer Therapy & Radiation Oncology, August 28-29, 2017 Brussels, Belgium; Oncologist & Diagnostics Conference, August 28-30, 2017 Brussels, Belgium; 2nd International Congress on Contemporary Issues in Women Cancers & Gynecologic Oncology, Aug 29-30, 2017 London, UK; 9th International Conference on Leukemia and Hematologic Oncology, October 05-06,2017,  London, UK; International Conference on Gastrointestinal Cancer and Therapeutics October 16-18, 2017 Baltimore, USA; 25th World Congress on Cancer Science and Therapy, October 18-20, 2017 Baltimore, Maryland, USA; World Congress on Radiology and Oncology, October 19-20, 2017 New York, USA; 25th World Cancer Conference, Oct 19-21, 2017 Rome, Italy; 9th International Conference on Biomarkers, October 26-28, 2017 Osaka, Japan; International Conference on Cancer Genetics and Epigenetics, October 26-28 2017, Osaka, Japan; 2nd International Congress on Epigenetics & Chromatin, November 06-08, 2017,Frankfurt, Germany; 14th Asia Pacific Oncologists Annual Meeting, November 20-22, 2017 Melbourne, Australia; 9th World Biomarkers Congress, December 07-08, 2017, Madrid, Spain; Global Summit on Oncology & Cancer, March 12-14, 2018, Singapore; 22nd Global Annual Oncologists Meeting, May 24-25, 2018 Osaka, Japan; Asia Pacific Cancer Conference, June 22-24, 2017, Seoul, Korea; Expediting Global Innovation in Precision Cancer Medicine, June 26-27, Paris; 4th international Michelangelo Conference Promises and challenges of developing new drugs in oncology, July 6-7, 2017;

Related associations:

European Association for Cancer Research, American Association for Cancer Research, American society of Clinical Oncology, American Cancer Society, Singapore Cancer Society, World Health Organization, American Childhood Cancer Organization, National Cancer Centre Singapore, Australia: Leukaemia Foundation, Australian & New Zealand Children’s Hematology/Oncology Group, Australian Prostate Cancer Research Centre.

Track 11: Oncogenomics Oncogenomics is a sub-field of genomics that portrays malignancy related qualities. It concentrates on genomic, epigenomic and transcript adjustments in Cancer. Malignancy is a genetic disease brought on by amassing of DNA transformations and epigenetic modifications prompting intemperate cell multiplication and neoplasm arrangement. The objective of Oncogenomics is to recognize new oncogenes or tumor silencer qualities that may give new bits of knowledge into growth analysis, foreseeing clinical result of cancer and new focuses for cancer treatments. The accomplishment of focused malignancy treatments, for example, Gleevec, Herceptin and Avastin raised the expectation for oncogenomics to clarify new focuses for cancer treatment.

Recommended Conferences:

World Cancer Congress, 1-4 October, 2017, Kuala Lumpur, Malaysia;59th American society of Hematology Annual Meeting & Exposition, December 9-12, Atlanta Georgia, United States; ESMO 2017 Congress, 8-12 September, 2017, Madrid, Spain;25th World Cancer Conference, 19-21, Rome, Italy; International Conference on Cancer Diagnostics, 27-28 November, Dubai, UAE;  2017 NCRI Cancer Conference, November 5-8, 2017 Liverpool; 19th World Cancer Conference, Nov 21-23, 2017 London; 26th World Cancer Convention, 27-28, November, 2017, Dubai, UAE; International Conference on Cancer Biology R&D and Market, September 18-19, 2017 Philadelphia, Pennsylvania, USA; 10th International Conference on Cancer Stem Cells and Oncology Research, June 26-28, 2017 London, UK; International Conference on Hematology and Oncology, June 29-July 01, 2017 Bangkok, Thailand; 19th Euro Congress on Cancer Science and Therapy, July 17-19, 2017 Lisbon, Portugal; 3rd Annual Conference on Gynecologic Oncology & Preventive Oncology, July 20-21, 2017 Chicago, Illinois, USA; 4th International Conference and Exhibition on Medical Physics and Biophysics, July 27-28, 2017 Rome, Italy; 20th Euro-Global Summit on Cancer Therapy & Radiation Oncology, August 28-29, 2017 Brussels, Belgium; Oncologist & Diagnostics Conference, August 28-30, 2017 Brussels, Belgium; 2nd International Congress on Contemporary Issues in Women Cancers & Gynecologic Oncology, Aug 29-30, 2017 London, UK; 9th International Conference on Leukemia and Hematologic Oncology, October 05-06,2017,  London, UK; International Conference on Gastrointestinal Cancer and Therapeutics October 16-18, 2017 Baltimore, USA; 25th World Congress on Cancer Science and Therapy, October 18-20, 2017 Baltimore, Maryland, USA; World Congress on Radiology and Oncology, October 19-20, 2017 New York, USA; 25th World Cancer Conference, Oct 19-21, 2017 Rome, Italy; 9th International Conference on Biomarkers, October 26-28, 2017 Osaka, Japan; International Conference on Cancer Genetics and Epigenetics, October 26-28 2017, Osaka, Japan; 2nd International Congress on Epigenetics & Chromatin, November 06-08, 2017,Frankfurt, Germany; 14th Asia Pacific Oncologists Annual Meeting, November 20-22, 2017 Melbourne, Australia; 9th World Biomarkers Congress, December 07-08, 2017, Madrid, Spain; Global Summit on Oncology & Cancer, March 12-14, 2018, Singapore; 22nd Global Annual Oncologists Meeting, May 24-25, 2018 Osaka, Japan; Asia Pacific Cancer Conference, June 22-24, 2017, Seoul, Korea; Expediting Global Innovation in Precision Cancer Medicine, June 26-27, Paris; 4th international Michelangelo Conference Promises and challenges of developing new drugs in oncology, July 6-7, 2017;

Related associations:

European Association for Cancer Research, American Association for Cancer Research, American society of Clinical Oncology, American Cancer Society, Singapore Cancer Society, World Health Organization, American Childhood Cancer Organization, National Cancer Centre Singapore, Australia: Leukaemia Foundation, Australian & New Zealand Children’s Hematology/Oncology Group, Australian Prostate Cancer Research Centre.

Track 12: Oncology and Hematology The Division of Oncology and Hematology is occupied with the determination and treatment of all malignancies (growths) that happen in grown-ups. Treatment may incorporate chemotherapy and immunotherapy, or pathway coordinated operators. High measurement treatment with bone marrow or fringe immature microorganism transplantation is additionally accessible. The Division of Oncology's doctors spend significant time in a wide range of growths including: lymphomas, leukemia, different myeloma, urologic, bosom, lung, gastrointestinal, mind malignancy, melanoma, and all other strong tumors.

Recommended Conferences:

World Cancer Congress, 1-4 October, 2017, Kuala Lumpur, Malaysia;59th American society of Hematology Annual Meeting & Exposition, December 9-12, Atlanta Georgia, United States; ESMO 2017 Congress, 8-12 September, 2017, Madrid, Spain;25th World Cancer Conference, 19-21, Rome, Italy; International Conference on Cancer Diagnostics, 27-28 November, Dubai, UAE;  2017 NCRI Cancer Conference, November 5-8, 2017 Liverpool; 19th World Cancer Conference, Nov 21-23, 2017 London; 26th World Cancer Convention, 27-28, November, 2017, Dubai, UAE; International Conference on Cancer Biology R&D and Market, September 18-19, 2017 Philadelphia, Pennsylvania, USA; 10th International Conference on Cancer Stem Cells and Oncology Research, June 26-28, 2017 London, UK; International Conference on Hematology and Oncology, June 29-July 01, 2017 Bangkok, Thailand; 19th Euro Congress on Cancer Science and Therapy, July 17-19, 2017 Lisbon, Portugal; 3rd Annual Conference on Gynecologic Oncology & Preventive Oncology, July 20-21, 2017 Chicago, Illinois, USA; 4th International Conference and Exhibition on Medical Physics and Biophysics, July 27-28, 2017 Rome, Italy; 20th Euro-Global Summit on Cancer Therapy & Radiation Oncology, August 28-29, 2017 Brussels, Belgium; Oncologist & Diagnostics Conference, August 28-30, 2017 Brussels, Belgium; 2nd International Congress on Contemporary Issues in Women Cancers & Gynecologic Oncology, Aug 29-30, 2017 London, UK; 9th International Conference on Leukemia and Hematologic Oncology, October 05-06,2017,  London, UK; International Conference on Gastrointestinal Cancer and Therapeutics October 16-18, 2017 Baltimore, USA; 25th World Congress on Cancer Science and Therapy, October 18-20, 2017 Baltimore, Maryland, USA; World Congress on Radiology and Oncology, October 19-20, 2017 New York, USA; 25th World Cancer Conference, Oct 19-21, 2017 Rome, Italy; 9th International Conference on Biomarkers, October 26-28, 2017 Osaka, Japan; International Conference on Cancer Genetics and Epigenetics, October 26-28 2017, Osaka, Japan; 2nd International Congress on Epigenetics & Chromatin, November 06-08, 2017,Frankfurt, Germany; 14th Asia Pacific Oncologists Annual Meeting, November 20-22, 2017 Melbourne, Australia; 9th World Biomarkers Congress, December 07-08, 2017, Madrid, Spain; Global Summit on Oncology & Cancer, March 12-14, 2018, Singapore; 22nd Global Annual Oncologists Meeting, May 24-25, 2018 Osaka, Japan; Asia Pacific Cancer Conference, June 22-24, 2017, Seoul, Korea; Expediting Global Innovation in Precision Cancer Medicine, June 26-27, Paris; 4th international Michelangelo Conference Promises and challenges of developing new drugs in oncology, July 6-7, 2017;

Related associations:

European Association for Cancer Research, American Association for Cancer Research, American society of Clinical Oncology, American Cancer Society, Singapore Cancer Society, World Health Organization, American Childhood Cancer Organization, National Cancer Centre Singapore, Australia: Leukaemia Foundation, Australian & New Zealand Children’s Hematology/Oncology Group, Australian Prostate Cancer Research Centre.

Track 13: Growth Epidemiology The investigation of malady transmission is the review and examination of the cases, causes, and effects of prosperity and disease conditions in portrayed famously. It is the establishment of general prosperity, and shapes course of action decisions and confirmation based practice by recognizing risk segments for infirmity and centers for preventive human administrations. Ailment transmission specialists help with study diagram, amassing, and quantifiable examination of data, change interpretation and spread of results (numbering peer overview and irregular exact review). The investigation of malady transmission has made framework used as a piece of clinical research, general prosperity ponders, and, to a lesser degree, basic research in the regular sciences.

Recommended Conferences:

World Cancer Congress, 1-4 October, 2017, Kuala Lumpur, Malaysia;59th American society of Hematology Annual Meeting & Exposition, December 9-12, Atlanta Georgia, United States; ESMO 2017 Congress, 8-12 September, 2017, Madrid, Spain;25th World Cancer Conference, 19-21, Rome, Italy; International Conference on Cancer Diagnostics, 27-28 November, Dubai, UAE;  2017 NCRI Cancer Conference, November 5-8, 2017 Liverpool; 19th World Cancer Conference, Nov 21-23, 2017 London; 26th World Cancer Convention, 27-28, November, 2017, Dubai, UAE; International Conference on Cancer Biology R&D and Market, September 18-19, 2017 Philadelphia, Pennsylvania, USA; 10th International Conference on Cancer Stem Cells and Oncology Research, June 26-28, 2017 London, UK; International Conference on Hematology and Oncology, June 29-July 01, 2017 Bangkok, Thailand; 19th Euro Congress on Cancer Science and Therapy, July 17-19, 2017 Lisbon, Portugal; 3rd Annual Conference on Gynecologic Oncology & Preventive Oncology, July 20-21, 2017 Chicago, Illinois, USA; 4th International Conference and Exhibition on Medical Physics and Biophysics, July 27-28, 2017 Rome, Italy; 20th Euro-Global Summit on Cancer Therapy & Radiation Oncology, August 28-29, 2017 Brussels, Belgium; Oncologist & Diagnostics Conference, August 28-30, 2017 Brussels, Belgium; 2nd International Congress on Contemporary Issues in Women Cancers & Gynecologic Oncology, Aug 29-30, 2017 London, UK; 9th International Conference on Leukemia and Hematologic Oncology, October 05-06,2017,  London, UK; International Conference on Gastrointestinal Cancer and Therapeutics October 16-18, 2017 Baltimore, USA; 25th World Congress on Cancer Science and Therapy, October 18-20, 2017 Baltimore, Maryland, USA; World Congress on Radiology and Oncology, October 19-20, 2017 New York, USA; 25th World Cancer Conference, Oct 19-21, 2017 Rome, Italy; 9th International Conference on Biomarkers, October 26-28, 2017 Osaka, Japan; International Conference on Cancer Genetics and Epigenetics, October 26-28 2017, Osaka, Japan; 2nd International Congress on Epigenetics & Chromatin, November 06-08, 2017,Frankfurt, Germany; 14th Asia Pacific Oncologists Annual Meeting, November 20-22, 2017 Melbourne, Australia; 9th World Biomarkers Congress, December 07-08, 2017, Madrid, Spain; Global Summit on Oncology & Cancer, March 12-14, 2018, Singapore; 22nd Global Annual Oncologists Meeting, May 24-25, 2018 Osaka, Japan; Asia Pacific Cancer Conference, June 22-24, 2017, Seoul, Korea; Expediting Global Innovation in Precision Cancer Medicine, June 26-27, Paris; 4th international Michelangelo Conference Promises and challenges of developing new drugs in oncology, July 6-7, 2017;

Related associations:

European Association for Cancer Research, American Association for Cancer Research, American society of Clinical Oncology, American Cancer Society, Singapore Cancer Society, World Health Organization, American Childhood Cancer Organization, National Cancer Centre Singapore, Australia: Leukaemia Foundation, Australian & New Zealand Children’s Hematology/Oncology Group, Australian Prostate Cancer Research Centre.

Track 14: Obesity and Cancer Obesity is a condition in which a man has an undesirable sum as well as appropriation of body fat. Almost the greater part of the confirmation connecting weight to tumor chance originates from vast associate reviews, a kind of observational review. In any case, information from observational reviews can be hard to translate and can't absolutely build up that heftiness causes tumor. That is on the grounds that large or overweight individuals may vary from fit individuals in courses other than their muscle to fat quotients, and it is said that these different contrasts, as opposed to their muscle to fat quotients—are what clarifies their diverse tumor chance. Stout individuals frequently have ceaseless low-level aggravation, which can, after some time, cause DNA harm that prompts growth. Regardless of the constraints of the review plans, there is reliable proof that higher measures of muscle to fat quotients are related with expanded dangers of various tumors.

Recommended Conferences:

World Cancer Congress, 1-4 October, 2017, Kuala Lumpur, Malaysia;59th American society of Hematology Annual Meeting & Exposition, December 9-12, Atlanta Georgia, United States; ESMO 2017 Congress, 8-12 September, 2017, Madrid, Spain;25th World Cancer Conference, 19-21, Rome, Italy; International Conference on Cancer Diagnostics, 27-28 November, Dubai, UAE;  2017 NCRI Cancer Conference, November 5-8, 2017 Liverpool; 19th World Cancer Conference, Nov 21-23, 2017 London; 26th World Cancer Convention, 27-28, November, 2017, Dubai, UAE; International Conference on Cancer Biology R&D and Market, September 18-19, 2017 Philadelphia, Pennsylvania, USA; 10th International Conference on Cancer Stem Cells and Oncology Research, June 26-28, 2017 London, UK; International Conference on Hematology and Oncology, June 29-July 01, 2017 Bangkok, Thailand; 19th Euro Congress on Cancer Science and Therapy, July 17-19, 2017 Lisbon, Portugal; 3rd Annual Conference on Gynecologic Oncology & Preventive Oncology, July 20-21, 2017 Chicago, Illinois, USA; 4th International Conference and Exhibition on Medical Physics and Biophysics, July 27-28, 2017 Rome, Italy; 20th Euro-Global Summit on Cancer Therapy & Radiation Oncology, August 28-29, 2017 Brussels, Belgium; Oncologist & Diagnostics Conference, August 28-30, 2017 Brussels, Belgium; 2nd International Congress on Contemporary Issues in Women Cancers & Gynecologic Oncology, Aug 29-30, 2017 London, UK; 9th International Conference on Leukemia and Hematologic Oncology, October 05-06,2017,  London, UK; International Conference on Gastrointestinal Cancer and Therapeutics October 16-18, 2017 Baltimore, USA; 25th World Congress on Cancer Science and Therapy, October 18-20, 2017 Baltimore, Maryland, USA; World Congress on Radiology and Oncology, October 19-20, 2017 New York, USA; 25th World Cancer Conference, Oct 19-21, 2017 Rome, Italy; 9th International Conference on Biomarkers, October 26-28, 2017 Osaka, Japan; International Conference on Cancer Genetics and Epigenetics, October 26-28 2017, Osaka, Japan; 2nd International Congress on Epigenetics & Chromatin, November 06-08, 2017,Frankfurt, Germany; 14th Asia Pacific Oncologists Annual Meeting, November 20-22, 2017 Melbourne, Australia; 9th World Biomarkers Congress, December 07-08, 2017, Madrid, Spain; Global Summit on Oncology & Cancer, March 12-14, 2018, Singapore; 22nd Global Annual Oncologists Meeting, May 24-25, 2018 Osaka, Japan; Asia Pacific Cancer Conference, June 22-24, 2017, Seoul, Korea; Expediting Global Innovation in Precision Cancer Medicine, June 26-27, Paris; 4th international Michelangelo Conference Promises and challenges of developing new drugs in oncology, July 6-7, 2017;

Related associations:

European Association for Cancer Research, American Association for Cancer Research, American society of Clinical Oncology, American Cancer Society, Singapore Cancer Society, World Health Organization, American Childhood Cancer Organization, National Cancer Centre Singapore, Australia: Leukaemia Foundation, Australian & New Zealand Children’s Hematology/Oncology Group, Australian Prostate Cancer Research Centre.

Track 15: Cancer Management and PreventionCancer prevention is action made to bring down the danger of getting cancer. This can incorporate maintaining healthy lifestyle, maintaining a strategic distance from presentation to known tumor causing substances, and taking prescriptions or immunizations that can keep malignancy from developing.

Recommended Conferences:

World Cancer Congress, 1-4 October, 2017, Kuala Lumpur, Malaysia;59th American society of Hematology Annual Meeting & Exposition, December 9-12, Atlanta Georgia, United States; ESMO 2017 Congress, 8-12 September, 2017, Madrid, Spain;25th World Cancer Conference, 19-21, Rome, Italy; International Conference on Cancer Diagnostics, 27-28 November, Dubai, UAE;  2017 NCRI Cancer Conference, November 5-8, 2017 Liverpool; 19th World Cancer Conference, Nov 21-23, 2017 London; 26th World Cancer Convention, 27-28, November, 2017, Dubai, UAE; International Conference on Cancer Biology R&D and Market, September 18-19, 2017 Philadelphia, Pennsylvania, USA; 10th International Conference on Cancer Stem Cells and Oncology Research, June 26-28, 2017 London, UK; International Conference on Hematology and Oncology, June 29-July 01, 2017 Bangkok, Thailand; 19th Euro Congress on Cancer Science and Therapy, July 17-19, 2017 Lisbon, Portugal; 3rd Annual Conference on Gynecologic Oncology & Preventive Oncology, July 20-21, 2017 Chicago, Illinois, USA; 4th International Conference and Exhibition on Medical Physics and Biophysics, July 27-28, 2017 Rome, Italy; 20th Euro-Global Summit on Cancer Therapy & Radiation Oncology, August 28-29, 2017 Brussels, Belgium; Oncologist & Diagnostics Conference, August 28-30, 2017 Brussels, Belgium; 2nd International Congress on Contemporary Issues in Women Cancers & Gynecologic Oncology, Aug 29-30, 2017 London, UK; 9th International Conference on Leukemia and Hematologic Oncology, October 05-06,2017,  London, UK; International Conference on Gastrointestinal Cancer and Therapeutics October 16-18, 2017 Baltimore, USA; 25th World Congress on Cancer Science and Therapy, October 18-20, 2017 Baltimore, Maryland, USA; World Congress on Radiology and Oncology, October 19-20, 2017 New York, USA; 25th World Cancer Conference, Oct 19-21, 2017 Rome, Italy; 9th International Conference on Biomarkers, October 26-28, 2017 Osaka, Japan; International Conference on Cancer Genetics and Epigenetics, October 26-28 2017, Osaka, Japan; 2nd International Congress on Epigenetics & Chromatin, November 06-08, 2017,Frankfurt, Germany; 14th Asia Pacific Oncologists Annual Meeting, November 20-22, 2017 Melbourne, Australia; 9th World Biomarkers Congress, December 07-08, 2017, Madrid, Spain; Global Summit on Oncology & Cancer, March 12-14, 2018, Singapore; 22nd Global Annual Oncologists Meeting, May 24-25, 2018 Osaka, Japan; Asia Pacific Cancer Conference, June 22-24, 2017, Seoul, Korea; Expediting Global Innovation in Precision Cancer Medicine, June 26-27, Paris; 4th international Michelangelo Conference Promises and challenges of developing new drugs in oncology, July 6-7, 2017;

Related associations:

European Association for Cancer Research, American Association for Cancer Research, American society of Clinical Oncology, American Cancer Society, Singapore Cancer Society, World Health Organization, American Childhood Cancer Organization, National Cancer Centre Singapore, Australia: Leukaemia Foundation, Australian & New Zealand Children’s Hematology/Oncology Group, Australian Prostate Cancer Research Centre.

World Cancer Meeting 2017 is designed to facilitate the dissemination and application of research findings related to cancer for International medical professionals and oncologists .It provides an opportunity to meet and communicate with leading doctors, surgeons, scientists, academic professionals from around the world and listen to top speakers about the on new developments that impact and advance the future of cancer science. It is an extraordinary event that invites participants from different leading universities, clinical research institutions and various diagnostic companies to share their research experiences in all aspects of this rapidly expanding field and thereby provides a list of new techniques.

Cancer is the second leading cause of death worldwide and in all regions of the world except sub-Saharan Africa. Historically, the UAE had a much lower incidence of cancer than Western countries; however, over the last 40 years, it has undergone a period of dramatic economic, social, and demographic change, resulting in increased life expectancy and prosperity. The Scope of Cancer Science & Therapy Conference is to inform the scientific community about all innovative aspects regarding cancer diseases. The participants can gather knowledge about the topics like Cancer, Cell Biology, Organ Specific Cancers, and Advances in Treatment Approaches, Cancer Genetics, Anti-Cancer Therapies, Cancer Immuno science, Cancer Diagnosis, Stem Cell Therapy, Treatment trough Precision Medicine, Cancer Management and Prevention, Economic Aspects of Cancer Therapies.

With individuals from around the globe concentrated on finding out about Cancers; this is your best chance to achieve the biggest array of members from the International Cancer Societies and Associations to direct Workshops , convey data, meet with present and potential researchers, make a sprinkle with new medication advancements, and get name acknowledgment at this 2-days occasion. Incredibly famous speakers, the latest methods, improvements, and the most up to date overhauls in Gynecologic Cancers are signs of this meeting.

Scope and importance

Cancer is considered to be one of the leading causes of morbidity and mortality worldwide. It is a complex health problem that requires a multidisciplinary approach. This approach is far reaching and ranges from health promotion to prevention and screening, diagnosis, treatment, rehabilitation and palliative caret’s crucial to remember that cancer is not one disease – it’s more than 200, all different, unique diseases, which require different approaches for treatment. Treatments that work for some cancers don’t work for others and sometimes those treatments simply stop working. Cancer research can span from cancer prevention to laboratory research, from clinical trials to quality-of-life research for survivors.

Why Melbourne?

Melbourne, the capital of Victoria, is the second biggest city in Australia. The City of Melbourne's populace is comprised of many gatherings of individuals of any age and from a wide range of societies. Occupants incorporate youthful experts, worldwide understudies and more seasoned couples hoping to appreciate everything the city brings to the table. The whole Melbourne metropolitan zone covers 9990.5 km2 and has a populace of around 4.5 million. On a normal weekday around 909,000 individuals utilize the city, and every year Melbourne has over a million global guests. Melbourne was initially settled by graziers, John Batman being the first. He asserted land only north of Port Phillip Bay, while different graziers likewise chosen to involve ranges close to the Yarra River, yet without the essential authorization to colonize. 

Conference Highlights

·         Cancer

·         Cancer Biology

·         Cancer Genetics

·         Precision Medicine and Cancer Therapy

·         Cancer Diagnosis and Cancer Diagnostics

·         Stem Cell Therapy

·         Cancer Case Reports

·         Novel Approaches to Cancer Therapeutics

·         Cancer Screening

·         Resistance and Tumor Evolution

·         Oncogenomics

·         Oncology and Hematology

·         Cancer Epidemoilogy

·         Obesity and Cancer

·         Cancer Management and Prevention

 

Why to attend?

Enlightening public with recent advances in Cancer diagnosis and therapy from around the world focused on cancer about recent advances in Cancer diagnosis and therapy, this is your single best opportunity to reach the largest assemblage of participants .World-renowned speakers, the most recent techniques, and the newest updates in cancer research fields are hallmarks of this conference.

Target audiences at Cancer and Oncology conferences

  • Cancer research Students, Scientists
  • Cancer Researchers
  • Cancer research Faculty
  • Medical Colleges
  • Cancer Associations and Societies
  • Oncologists
  • Radiologists
  • Chemotherapists
  • Pathologists
  • Physicians
  • Business Entrepreneurs
  • Medical Devices Manufacturing Companies
  • Pharmaceutical Companies
  • Diagnostics Companies
  • Testimonials

Major associations around the world

·         European Association for Cancer Research

·         National Cancer Centre Singapore

·         American Association for Cancer Research

·         American society of Clinical Oncology

·         American Cancer Society

·         Singapore Cancer Society

·         World Health Organization

·         American Childhood Cancer Organization

·         National Cancer Centre Singapore

·         Emirates Society of Hematology

·         Emirates Society of Hematology

·         European Cancer Organisation

·         European Cervical Cancer Association ,

·         European Head and Neck cancer Awareness

·         European Hematology Association

·         European society of molecular imaging

·         Foundation for Head and Neck Oncology

·         Gastrointestinal Society

·         German Cancer Research Centre

·         German Society for Oncological Pharmacy

·         Gromada Head & Neck Cancer Foundation

·         Hairy cell leukaemia (HCL) | Lymphoma Association

·         Head and Neck Cancer Alliance

·         IAOO: International Academy of Oral Oncology

·         Indonesia: Indonesian CML & GIST Community (ELGEKA Indonesia)

·         International Academy of Oral Oncology

·         International Agency for Research on Cancer

·         International Cancer Genome Consortium

·         International Federation for Cervical Pathology and Colposcopy,

·         International Melanoma Working Group

·         International Myeloma Foundation

·         International society for oncology and biomarkers

·         Irish Cancer Society

·         Israel Cancer Research Fund

·         Korean Breast Cancer society,

·         Latvia: Association of Support for Leukemia Patients (Leikemijas slimnieku atbalsta biedriba)

·         Leukemia & Lymphoma Foundation

·         Leukemia & Lymphoma Society

·         Lymphoma Association

·         Lymphoma Coalition

·         Lymphoma Foundation Canada

·         Lymphoma Research Foundation of America

·         Medical Centre Cologne

·         Foundation Acute

·         Alzheimer's Association

·         American Association for Cancer Research

·         American Association Oral and Maxillofacial Surgery

·         American Brain Tumor Association

·         American Brest Cancer Foundation,

·         American Childhood Cancer Organisation

·         American Society for Blood & Marrow Transplantation(ASBMT)

·         American Society for Colposcopy and Cervical Pathology ,

·         American Society of Hematology

·         American Society of Pediatric Hematology/Oncology

·         APHCON Home: ASIA-PACIFIC HEMATOLOGY CONSORTI

·         Asian and Pacific Federation of Organization for Cancer Research and Control,

·         Association for Molecular Pathology

·         Australia: Leukaemia Foundation

·         Australian & New Zealand Children’s Hematology/Oncology Group

·         Australian Prostate Cancer Research Centre

·         BC Cancer Foundation

·         Biomarkers profile corporation

·         Biomarkers society

·         Bone Marrow Transplants - Neutropenia Support Association Inc.

·         British Association of Urological Surgeons (BAUS)

·         Canadian Cancer Society

·         Cancer Association of Botswana

·         Cancer Research Institute

·         Cancer Research Institute, USA

·         Cancer Research Society

·         Cancer Research UK

·         Cancer Society of America

·         Child Cancer Foundation

·         Childhood Cancer Research Group

·         Childhood Leukemia Foundation

·         Children with Cancer UK

·         Children’s Cancer and Leukaemia Group

·         Children's Leukemia Rese

Top industries associated

There are many Pharmaceutical Companies manufacture the Cancer Drugs. The major Companies are;

·         Roche

·         Novartis

·         Celgene

·         Johnson & Johnson

·         Bristol-Myers Squibb

·         Lilly

·         Takeda

·         AstraZeneca

·         Pfizer

·         Merck & Co

·         Bayer

·         UCB

 

Market growth of Cancer in the last and upcoming years:

Around 12.7 million malignancy cases and 7.6 million disease passings are evaluated to have happened in 2008 around the world, with 56% of the cases and 64% of the passings in the financially creating world. Breast tumor, the most widely recognized tumor in ladies, displays a high survival rate: 83% of patients have survived this sort of growth following five years. Lung disease is a standout amongst the most forceful tumors and survival following five years is low: just 10% of patients determined to have a harmful neoplasm make due for over five years. Colorectal growth (of the colon and rectum), the most widely recognized harmful tumor in the event that we gather men and ladies together, presents a normal survival rate of 50-55% five years after finding, implying that a large portion of the patients survive this type of malignancy. Prostate growth, today the most well-known tumor in men, has an undeniably ideal forecast, with a worldwide survival rate of 76%, which is higher in youthful grown-ups. Ovarian malignancy exhibits an exceptionally changed guess contingent upon age: while 70% of the gathering somewhere around 15 and 44 years survives this type of disease, this is the situation for just 19% of those more than 74 years of age.

The global cancer/tumor profiling market was valued at $13.30 billion in 2012. At the end of 2013, the market is estimated to be $14.99 billion and is poised to reach around $35 billion by 2018, growing at a CAGR of 18.50% from 2013 to 2018. Global oncology spending hit $91 billion for 2013 and it's growing at a 5% clip annually, which will cross $100 billion in 2015. The key players in the cancer/tumor profiling market are Boreal Genomics Inc. (U.S.), Genomic Health Inc. (U.S.), Life Technologies Corporation (U.S.), Oncogenomics Laboratories (U.S.), Oxford Gene Technology Ltd. (U.K.), Precision Therapeutics Inc. (U.S.), Proteome Sciences PLC (U.K.), Agendia (The Netherlands), Nano string Technologies (U.S.) and RiboMed BiotechnologiesInc. (U.S.). Global cancer diagnostics market is expected to reach $13.1 Billion in 2020 from an estimated $7.1 Billion in 2015, growing at a CAGR of 12.9%. The market is dominated by North America, followed by Europe, Asia, and Rest of the World (RoW). The cancer diagnostics market in Asia is expected to grow at the highest rate from 2015 to 2020. According to the market the global oncology drugs market is expected to reach at $111.9 billion by 2020. Patent expiration of key cancer drugs such as Herceptin, Erbitux, Rituxan and Avastin, is expected to boost the growth of cancer biosimilars market by 2020.

  • Cancer
  • Cancer Biology
  • Cancer Genetics
  • Precision Medicine and Cancer Therapy
  • Cancer Diagnosis and Cancer Diagnostics
  • Stem Cell Therapy
  • Cancer Case Reports
  • Novel Approaches to Cancer Therapeutics
  • Cancer screening
  • Resistance and Tumor Evolution
  • Oncogenomics
  • Oncology and Hematology
  • Cancer Epidemiology
  • Obesity and Cancer
  • Cancer Management and Prevention